Quantitative analysis of topoisomerase II alpha and evaluation of its effects on cell proliferation and apoptosis in glioblastoma cancer stem cells

Neuroscience Letters

Volumn 518, Issue 2, 2012, Pages 138-143

  Hong, Yang ^a   Sang, Meng ^a   Shang, Chao ^a   Xue, Yi xue ^a   Liu, Yun hui ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Cancer stem cells; Glioblastoma multiforme; Topoisomerase II alpha; U87

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE II ALPHA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER STEM CELL; CELL CYCLE ARREST; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE SILENCING; GLIOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

ANTIGENS, NEOPLASM; APOPTOSIS; BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA TOPOISOMERASES, TYPE II; DNA-BINDING PROTEINS; FLOW CYTOMETRY; GLIOBLASTOMA; HUMANS; NEOPLASTIC STEM CELLS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84861678405     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.04.071     Document Type: Article

References (23)

1. Akimitsu N., Kamwa K., Tone S., Sakaguchi A., Kikiichi A., Hamamoto H. Induction of apoptosis by depletion of DNA topoisomerase IIa in maimruilian cells. Biochemical and Biophysical Research Communications 2003, 307:301-307.
2. Badiga A.V., Chetty C., Kesanakurti D., Are D., Gujrati M., Klopfenstein J.D., Dinh D.H., Rao J.S. MMP-2 siRNA inhibits radiation-enhanced invasiveness in glioma cells. PLoS One 2011, 6:e20614.
3. Berger J.M., Gamblin S.J., Harrison S.C., Wang J.C. Structure and mechanism of DNA topoisomerase II. Nature 1996, 379:225-232.
4. Benjamin R., Capparella J., Brown A. Classification of glioblastoma multiforme in adults by molecular genetics. Cancer Journal 2003, 9:82-90.
5. Das C.M., Aguilera D., Vasquez H., Prasad P., Zhang M., Wolff J.E., Gopalakrishnan V. Valproic acid induces p21 and topoisomerase-II (alpha/beta) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines. Journal of Neuro-Oncology 2007, 85:159-170.
6. Faria M.H., Gonçalves B.P., do Patrocínio R.M., de Moraes-Filho M.O., Rabenhorst S.H. Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status. Neuropathology 2006, 26:519-527.
7. Galli R., Binda E., Orfanelli U., Cipelletti B., Gritti A., De Vitis S., Fiocco R., Foroni C., Dimeco F., Vescovi A. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Research 2004, 64:7011-7021.
8. Gray M.D., Mann M., Nitiss J.L., Hendershol L.M. Activation of tlie tinfolded protein response is necessary and suftlcicnt for reducing topoisomcrase IIa protein levels and decreasing sensitivity to topoisomerase-targeted drugs. Molecular Pharmacology 2005, 68:1699-1707.
9. Kellner U., Sehested M., Jensen P.B., Gieseler F., Rudolph P. Culprit and victim-DNA topoisomerase II. Lancet Oncology 2002, 3:235-243.
10. Lee J., Kotliarova S., Kotliarov Y., Li A., Su Q., Donin N.M., Pastorino S., Purow B.W., Christopher N., Zhang W. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006, 9:391-403.
11. Panousis D., Patsouris E., Lagoudianakis E., Pappas A., Kyriakidou V., Voulgaris Z., Xepapadakis G., Manouras A., Athanassiadou A.M., Athanassiadou P. The value of TOP2A, EZH2 and paxillin expression as markers of aggressive breast cancer: relationship with other prognostic factors. European Journal of Gynaecological Oncology 2011, 32:156-159.
12. Pollard S.M., Yoshikawa K., Clarke I.D., Danovi D., Stricker S., Russell R., Bayani J., Head R., Lee M., Bernstein M. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 2009, 4:568-580.
13. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
14. Rich J.N., Eyler C.E. Cancer stem cells in brain tumor biology. Cold Spring Harbor Symposia on Quantitative Biology 2008, 73:411-420.
15. Sanai N., Alvarez-Buylla A., Berger M.S. Neural stem cells and the origin of gliomas. New England Journal of Medicine 2005, 353:811-822.
16. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., Dirks P.B. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
17. Stiles C.D., Rowitch D.H. Glioma stem cells: a midterm exam. Neuron 2008, 58:832-846.
18. Taniguchi K., Wakabayashi T., Yoshida T., Mizuno M., Yoshikawa K., Kikuchi A., Nakashima N., Yoshida J. Immunohistochemical staining of DNA topoisomerase IIalpha in human gliomas. Journal of Neurosurgery 1999, 91:477-482.
19. Vescovi A.L., Galli R., Reynolds B.A. Brain tumour stem cells. Nature Reviews Cancer 2006, 6:425-436.
20. Villman K., Ståhl E., Liljegren G., Tidefelt U., Karlsson M.G. Topoisomerase II-alpha expression in different cell cycle phases in fresh human breast carcinomas. Modern Pathology 2002, 15:486-491.
21. Wang J.C. Evaluating therapeutic efficacy against cancer stem cells: new challenges posed by a new paradigm. Cell Stem Cell 2007, 1:497-501.
22. Watt P.M., Hickson I.D. Structure and function of type II DNA topoisomerases. Biochemical Journal 1994, 303:681-695.
23. Yuan X., Curtin J., Xiong Y., Liu G., Waschsmann-Hogiu S., Farkas D.L., Black K.L., Yu J.S. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 2004, 23:9392-9400.